- Projects & figures
- News & Events
- Managing your project
- About ERC
Can highly automated vehicles fare better than traditional cars in traffic gridlock conditions? Cooperation between vehicle intelligent transport systems via connected vehicles may provide a solution.
The use and misuse of antibiotics has accelerated the emergence of drug-resistant bacterial strains, threatening our ability to treat common diseases. EU-funded research has shed new light on the mechanisms behind these microbial mutations, with implications for our understanding of diseases and resistance to treatment.
Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.
ERC grantee Marta Moita and her team use cutting-edge experimental procedures to investigate how rats and flies learn to appropriately respond to danger from other individuals. The results of her study may teach us a lot about our own brains, and shed light on diseases that impair social behaviour.
The European Court of Human Rights (ECtHR) makes decisions on religious freedom that affect the rights of over 800 million people in 47 countries. A famous case is the Lautsi v. Italy decision which prevented the display of the crucifix in classrooms, and was later revoked after a public outcry.
Dr Effie Fokas, a Greek researcher, has received an ERC Starting grant to study the influence of ECtHR decisions on the public. Looking beyond the legal implementation of the decisions, she hopes to discover how they change local perceptions of religious rights, grassroots movements and national case law.
Pursuing a sustainable development and broadening social justice and cohesion are some of the challenges that Europe is currently facing. What if we could learn how to solve these challenges by using the social and political innovations taking place in different corners of the globe? Professor Boaventura de Sousa Santos suggests that a new approach can be developed in Europe based on the diversity of practices elsewhere.
Forget USA, Japan; the field of transparent electronics has put Portugal well and truly on the map thanks to Professor Elvira Fortunato and one of the largest grants awarded to a Portuguese scientist. The European Research Council grant contributed to the installation of the recently opened NOVA Nano-Fabrication Laboratory, of which Prof Fortunato is the Director.